GEP19970835B - Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone - Google Patents

Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone

Info

Publication number
GEP19970835B
GEP19970835B GEAP19942162A GEAP1994002162A GEP19970835B GE P19970835 B GEP19970835 B GE P19970835B GE AP19942162 A GEAP19942162 A GE AP19942162A GE AP1994002162 A GEAP1994002162 A GE AP1994002162A GE P19970835 B GEP19970835 B GE P19970835B
Authority
GE
Georgia
Prior art keywords
lower alkyl
sulphonamide
dihydroquinoline
oxo
quinolones
Prior art date
Application number
GEAP19942162A
Other languages
English (en)
Inventor
David Bryan Yates
Malcolm Freeman Sim
Raymond Parkinson
Kenneth John Nichol
James Fraser
Roy Victor Davies
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of GEP19970835B publication Critical patent/GEP19970835B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GEAP19942162A 1979-03-27 1994-09-07 Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone GEP19970835B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27

Publications (1)

Publication Number Publication Date
GEP19970835B true GEP19970835B (en) 1997-02-10

Family

ID=10504143

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19942162A GEP19970835B (en) 1979-03-27 1994-09-07 Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone

Country Status (10)

Country Link
JP (2) JPS55130960A (es)
BE (1) BE882443A (es)
CY (1) CY1343A (es)
ES (1) ES8104232A1 (es)
GB (1) GB2047691B (es)
GE (1) GEP19970835B (es)
JO (1) JO1072B1 (es)
MX (1) MX5950A (es)
SU (1) SU1124886A3 (es)
ZA (1) ZA801575B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents

Also Published As

Publication number Publication date
JPS55130960A (en) 1980-10-11
ES489929A0 (es) 1981-04-16
JPH0114224B2 (es) 1989-03-10
CY1343A (en) 1987-01-16
GB2047691B (en) 1983-07-20
ZA801575B (en) 1981-03-25
JPH0250086B2 (es) 1990-11-01
ES8104232A1 (es) 1981-04-16
GB2047691A (en) 1980-12-03
MX5950A (es) 1993-11-01
BE882443A (fr) 1980-09-26
JO1072B1 (en) 1982-07-10
JPS62215526A (ja) 1987-09-22
SU1124886A3 (ru) 1984-11-15

Similar Documents

Publication Publication Date Title
ES482134A1 (es) Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido.
IL103944A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
ES8106723A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ES8301481A1 (es) Procedimiento para la preparacion de nuevos compuestos heterociclos derivados de azepina.
ES529333A0 (es) Procedimiento para preparar derivados de piridazinona
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
EP0206616A3 (en) Quinolones having antihypertensive activity
ES8604543A1 (es) Procedimiento para la obtencion de derivados piperazinicos
DE2965377D1 (en) 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them
GEP19970835B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
ES8400440A1 (es) "procedimiento para preparar nuevas triazoloquinazolonas".
ES8403125A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
ATE137747T1 (de) Aminobenzolverbindungen, herstellung und verwendung
ES8407052A1 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
GEP19970838B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ES456991A1 (es) Procedimiento para la preparacion de 1,2,3-tiadiazol-5-il- ureas.
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
JPS5754169A (es)
ES8702399A1 (es) Un procedimiento para preparar derivdos de 1,5-benzoxatiepina
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ES2036600T3 (es) Procedimiento para preparar 1-(3-(2-dialquilaminoetoxi)-2-tienil)-3-fenil-1-propanonas.
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.
HUT34316A (en) Process for producing heterocyclic hydroximidates and thiohydroximidates and their carbamate-ester derivatives